News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
820,862 Results
Type
Article (67368)
Company Profile (800)
Press Release (752674)
Multimedia
Podcasts (180)
Webinars (24)
Section
Business (222029)
Career Advice (2961)
Deals (38040)
Drug Delivery (160)
Drug Development (87462)
Employer Resources (182)
FDA (17867)
Job Trends (16753)
News (376595)
Policy (36530)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3009)
Academic (1)
Accelerated approval (57)
ADA (48)
Adcomms (35)
Allergies (206)
Alliances (53958)
ALS (238)
Alzheimer's disease (1950)
Antibody-drug conjugate (ADC) (554)
Approvals (18270)
Artificial intelligence (794)
ASCO (341)
Autoimmune disease (358)
Automation (66)
Bankruptcy (386)
Best Places to Work (12591)
BIO (70)
BIOSECURE Act (23)
Biosimilars (246)
Biotechnology (466)
Bladder cancer (211)
Brain cancer (83)
Breast cancer (836)
Cancer (6574)
Cardiovascular disease (544)
Career advice (2511)
Career pathing (48)
CAR-T (381)
CDC (76)
Celiac Disease (3)
Cell therapy (1033)
Cervical cancer (56)
Clinical research (75875)
Collaboration (2381)
Commercialization (1)
Company closure (6)
Compensation (1541)
Complete response letters (99)
COVID-19 (2971)
CRISPR (125)
C-suite (1306)
Cystic fibrosis (166)
Data (8819)
Decentralized trials (3)
Denatured (41)
Depression (194)
Dermatology (97)
Diabetes (700)
Diagnostics (7535)
Digital health (66)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (392)
Drug pricing (234)
Drug shortages (37)
Duchenne muscular dystrophy (315)
Earnings (97711)
Editorial (79)
Employer branding (22)
Employer resources (161)
Events (133360)
Executive appointments (1205)
FDA (22002)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1962)
Gene editing (265)
Generative AI (70)
Gene therapy (816)
GLP-1 (1232)
Government (5320)
Grass and pollen (8)
Guidances (423)
Healthcare (21090)
Hematology (197)
HIV (95)
Huntington's disease (66)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (112)
Immunology and inflammation (340)
Immuno-oncology (113)
Indications (217)
Infectious disease (3372)
Inflammatory bowel disease (241)
Inflation Reduction Act (16)
Influenza (153)
Intellectual property (328)
Interviews (518)
IPO (17553)
IRA (60)
Job creations (4525)
Job search strategy (2094)
JPM (71)
Kidney cancer (22)
Labor market (114)
Layoffs (654)
Leadership (50)
Legal (8933)
Liver cancer (110)
Longevity (37)
Lung cancer (863)
Lymphoma (479)
Machine learning (68)
Management (65)
Manufacturing (1212)
Marketing (2)
MASH (221)
Medical affairs (1)
Medical device (15128)
Medtech (15304)
Mergers & acquisitions (21810)
Metabolic disorders (1782)
mRNA (257)
Multiple sclerosis (205)
NASH (23)
Neurodegenerative disease (502)
Neuropsychiatric disorders (123)
Neuroscience (3693)
Neurotech (1)
NextGen: Class of 2026 (7537)
Non-profit (5122)
Now hiring (83)
Obesity (840)
Opinion (365)
Ovarian cancer (245)
Pain (286)
Pancreatic cancer (366)
Parkinson's disease (421)
Partnered (37)
Patents (659)
Patient recruitment (784)
Peanut (71)
People (65292)
Pharmaceutical (132)
Pharmacy benefit managers (38)
Phase 1 (23622)
Phase 2 (33150)
Phase 3 (24870)
Pipeline (10001)
Policy (389)
Postmarket research (3042)
Preclinical (10371)
Press Release (72)
Prostate cancer (349)
Psychedelics (69)
Radiopharmaceuticals (374)
Rare diseases (1259)
Real estate (6993)
Recruiting (73)
Regulatory (28425)
Reports (57)
Research institute (2735)
Resumes & cover letters (473)
Rett syndrome (44)
RNA editing (26)
RSV (97)
Schizophrenia (195)
Series A (337)
Series B (246)
Service/supplier (27)
Sickle cell disease (127)
Special edition (31)
Spinal muscular atrophy (184)
Sponsored (49)
Startups (4102)
State (2)
Stomach cancer (19)
Supply chain (145)
Tariffs (100)
The Weekly (136)
Vaccines (1259)
Venture capital (131)
Weight loss (565)
Women's health (141)
Worklife (23)
Date
Today (92)
Last 7 days (452)
Last 30 days (2815)
Last 365 days (32280)
2026 (16760)
2025 (32176)
2024 (37582)
2023 (42334)
2022 (53733)
2021 (58536)
2020 (57499)
2019 (50971)
2018 (38654)
2017 (35176)
2016 (35271)
2015 (41443)
2014 (36463)
2013 (33581)
2012 (33571)
2011 (34025)
2010 (32884)
Location
Africa (991)
Alabama (101)
Alaska (7)
Arizona (395)
Arkansas (16)
Asia (46657)
Australia (8146)
California (14483)
Canada (4013)
China (1599)
Colorado (621)
Connecticut (647)
Delaware (447)
Europe (107253)
Florida (2170)
Georgia (470)
Hawaii (4)
Idaho (68)
Illinois (1233)
India (103)
Indiana (672)
Iowa (26)
Japan (611)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1746)
Massachusetts (10606)
Michigan (410)
Minnesota (805)
Mississippi (7)
Missouri (165)
Montana (37)
Nebraska (31)
Nevada (155)
New Hampshire (91)
New Jersey (3851)
New Mexico (33)
New York (3816)
North Carolina (1946)
North Dakota (11)
Northern California (7232)
Ohio (452)
Oklahoma (27)
Oregon (55)
Pennsylvania (2843)
Puerto Rico (33)
Rhode Island (55)
South America (1374)
South Carolina (89)
South Dakota (2)
Southern California (5714)
Tennessee (234)
Texas (2355)
United States (51774)
Utah (432)
Vermont (2)
Virginia (373)
Washington D.C. (89)
Washington State (1190)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
820,862 Results for "new chemical entities inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New Horizons in Psychiatric Innovation
February 22, 2026
·
11 min read
Press Releases
Battelle Wins New Contract to Continue Environmental Research on Endocrine-disrupting Chemicals
February 24, 2026
·
2 min read
Press Releases
Loop Chemicals Licenses Chemical Looping Ammonia Technology from Sandia National Laboratories
May 7, 2026
·
3 min read
Press Releases
Fujitsu and The University of Osaka develop new technologies for chemical material energy calculations on early-FTQC quantum computers
March 25, 2026
·
2 min read
Press Releases
BlossomHill Therapeutics Presents First Preclinical Data from New Pan-KRAS Inhibitor Program Built on a Novel Chemical Scaffold During Mini Symposium at AACR 2026
April 22, 2026
·
5 min read
Press Releases
SK Life Science, Inc. Announces FDA Acceptance for Review of New Drug Application for Cenobamate Oral Suspension
June 15, 2026
·
10 min read
Pharm Country
Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA
Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA) today announced that the Company’s lead product, YCANTH™, has received New Chemical Entity (“NCE”) Status and a listing in the Orange Book from the U.S. Food and Drug Administration (“FDA”), providing a minimum five years of regulatory exclusivity.
March 26, 2024
·
3 min read
BioMidwest
Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
Recursion announced it has signed an agreement with Bayer AG to in-license a new chemical entity that emerged from the companies’ fibrosis research collaboration.
January 4, 2024
·
4 min read
Press Releases
Modular Genetics, Inc. joins New American Industrial Alliance to Reindustrialize America
March 5, 2026
·
1 min read
Mergers & acquisitions
Incyte’s stars align as new CEO strikes $2B Vega takeover for blood disorder asset
Incyte is acquiring Vega Therapeutics, a subsidiary of Star Therapeutics, for a bleeding disorder program that analysts say has “pipeline-in-a-product” potential.
June 8, 2026
·
2 min read
·
Annalee Armstrong
1 of 82,087
Next
